Clearance Summary
SmartCardia 7L Platform (MCT) received FDA 510(k) clearance under submission number K240653, sponsored by Smartcardia SA. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2024-10-31.
- Submission: K240653
- Applicant / Sponsor: Smartcardia SA
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1025
- Decision date: 2024-10-31
Classification & Regulation
This clearance is catalogued under FDA product code QYX and 21 CFR 870.1025, within the Cardiovascular review panel as a Class II device.